Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
PneumoWave develops consumer-friendly health technology to monitor neuro-respiratory low-motion events (central apnea) in real time using ergonomic wearables and a smartphone-based interface. The system supports rapid intervention by alerting users or caregivers to prevent event escalation, leveraging reusable, power-efficient medical-grade devices. The company aims for a US clinic launch in 2026 and offers a modular platform providing full-stack health insights for clinicians and researchers, including AI-driven biomarker development and disease-specific datasets.
Parse Score